Astria Therapeutics to Current at Upcoming European Academy of Dermatology and Venerology Congress By Investing.com
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical firm centered on growing life-changing…
Galderma Reaffirms Its Leadership in Dermatology With Intensive Presence at EADV 2024 By Investing.com
Late-breaking displays will reveal necessary new knowledge from the section III OLYMPIA…
Almirall’s H1 2024 Outcomes: Almirall Delivers Robust Efficiency within the First Half of 2024, Reaching Web Gross sales Progress of 6.7% Pushed by Its European Dermatology Business and Accelerating Biologics By Investing.com
Robust progress trajectory maintained with Web Gross sales improve of 6.7% to…
